Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024

Description

Heart Attack Diagnostics Market Growth & Trends:

The global heart attack diagnostics market size is expected to reach USD 18.52 billion by 2030, according to a new report by Grand View Research, Inc. The heart attack diagnostics market is anticipated to grow at a CAGR of 8.2% during the forecast year from 2024 to 2030. The overall risk factors and the disease burden remains large, thereby rendering the heart attack diagnostic sectors a profitable growth prospect. This growth is attributed to a majority of factors, such as high prevalence of coronary heart diseases, increased tobacco smoking, and obesity, enhanced adoption of unhealthy diet is resulting in a high cholesterol incidence in individuals, particularly in the rising geriatric population. However, the low Medicare reimbursement provided for the mobile cardiac outpatient telemetry electrocardiogram (ECG) and the progressively declining heart attack incidence rates are expected to hamper the market growth.

The heart attack diagnostics market has been classified by product into electrocardiogram, which measures the electrical activity of the heart; echocardiogram, a form of ultrasound test that provides images of the heart; blood tests that measure the expression of certain proteins in excess, such as troponin levels, and cardiac enzymes; and other diagnostic products. The ECG segment is expected to witness a significant growth rate in developing countries, owing to the technological advances coupled with increasing applications of ECG. Although, the increasing demand for cost effective, rapid blood tests such as troponin and Creatine Kinase MB Isoenzyme (CK-MB) is likely to acquire major market share in the near future. The key countries landscape included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and Middle East. The Asia Pacific region is anticipated to be the fastest growing region during the forecast period. On the other hand, North America is estimated to dominate the global heart attack diagnostics market.

Heart Attack Diagnostics Market Report Highlights:

North America is estimated to dominate the global heart attack diagnostics market. The increasing awareness about heart attacks, its causative and risk factors, and enhanced uptake and acceptance of technologically advanced diagnostics is expected to contribute to the market growth.
The Asia Pacific region is expected to be the fastest growing region during the forecast period. to The reason being the considerably large burden of heart diseases in certain developing regions, such as in India, where 2.4 million people die annually due to heart diseases. As a result of the soaring incidences of heart diseases, an urgent requirement to undertake awareness measures and incorporate advanced diagnostics is expected to fuel the market growth.
The Troponin segment dominated the blood tests market and accounted for a share of 62.5% in 2023. Troponin T, a protein present in the heart muscle, is crucial in diagnosing heart attacks through a high-sensitivity troponin T test.

Product Code: GVR-1-68038-053-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Heart Attack Diagnostics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Heart Attack Diagnostics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Heart Attack Diagnostics Market: Test Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Heart Attack Diagnostics Market: Test Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Electrocardiogram
- 4.3.1. Electrocardiogram Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Blood Test
- 4.4.1. Blood Test Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.1. Troponin
    - 4.4.1.1.1. Troponin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.2. CK-MB
    - 4.4.1.2.1. CK-MB Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Others
- 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Heart Attack Diagnostics Market: End Use Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Heart Attack Diagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Hospitals
- 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Ambulatory Surgical Centers
- 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Others
- 5.5.1. Others Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Heart Attack Diagnostics Market: Regional Estimates & Trend Analysis

6.1. Heart Attack Diagnostics Market Share, By Region, 2023 & 2030, USD Billion
6.2. North America
- 6.2.1. North America Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.2.3. Canada
  - 6.2.3.1. Canada Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3. Europe
- 6.3.1. Europe Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.2. U.K.
  - 6.3.2.1. U.K. Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.3. Germany
  - 6.3.3.1. Germany Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.4. France
  - 6.3.4.1. France Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.5. Italy
  - 6.3.5.1. Italy Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.6. Spain
  - 6.3.6.1. Spain Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.8. Norway
  - 6.3.8.1. Norway Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.9. Sweden
  - 6.3.9.1. Sweden Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.2. China
  - 6.4.2.1. China Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.3. Japan
  - 6.4.3.1. Japan Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.4. India
  - 6.4.4.1. India Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.5. South Korea
  - 6.4.5.1. South Korea Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.6. Australia
  - 6.4.6.1. Australia Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Latin America
- 6.5.1. Latin America Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.2. Saudi Arabia
  - 6.6.2.1. Saudi Arabia Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.3. UAE
  - 6.6.3.1. UAE Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.4. South Africa
  - 6.6.4.1. South Africa Heart Attack Diagnostics Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Heart Attack Diagnostics Market Estimates and Forecasts, 2017 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. GE Healthcare
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Hitachi Corporation
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Koninklijke Philips NV
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Midmark Corporation
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. F Hoffmann-La Roche Ltd
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Schiller AG
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Siemens Healthineers
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Toshiba Corporation
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Welch Allyn Inc
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.10. Astrazaneca PLC
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiatives

Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030